DELV is a technology company.
DELV has raised $36.0M across 2 funding rounds.
DELV has raised $36.0M in total across 2 funding rounds.
Delv is an AI-powered search platform designed for researchers and data analysts in R&D, optimizing search workflows with tools like AI search agents, automatic document summaries, and visual data representations.[1][2][4] It serves over 100 individual users, including organizations like Alvea and Boston Children’s Hospital, by tackling research inefficiencies—such as data silos and technical comprehension gaps—enabling up to 75% more efficient processes; the company is exiting beta to a 5,000+ user waitlist and has raised $450K in seed funding.[1][2]
Founded in 2022 in San Francisco, Delv focuses on credible databases like PubMed to deliver specialized machine learning for highly technical scientific content, outperforming general AI assistants.[1][2]
Delv was founded in 2022 by Pranjali Awasthi, a then-16-year-old prodigy raised by academic parents with PhDs, immersing her in research and technology from an early age.[2] In 9th grade, she joined a research lab, building machine learning skills to bridge her knowledge gaps as the youngest member; this frustration with inefficient research directly inspired Delv as a "Copilot for research."[2]
Early traction came swiftly: serving 100+ users, securing seed funding from AngelList Quant Fund, On Deck, Backend Capital, and angels, with plans to launch publicly soon after.[2]
(Note: Distinct from unrelated entities like Delve.ai for compliance or marketing personas.[5][6])
Delv rides the AI agent and specialized search trend in R&D, where generative AI is transforming knowledge work amid exploding scientific data volumes from sources like PubMed.[1][2] Timing aligns with post-2022 AI boom, as labs and enterprises demand tools beyond generic LLMs for technical accuracy, fueled by market forces like rising R&D costs and data overload.[2][4]
By enabling faster insights for analysts at hospitals and firms, Delv influences the ecosystem, democratizing high-level research efficiency for startups and academics, potentially accelerating discoveries in biotech and beyond.[2]
Delv's trajectory points to rapid scaling post-beta, leveraging its waitlist and funding for enterprise expansion in AI-driven R&D tools.[2] Trends like agentic AI and domain-specific models will propel growth, as demand surges for precise, silo-busting search amid hyperspecialized data landscapes.
Its influence may evolve from niche research aid to broader platform, powering institutional workflows and shaping efficient innovation—cementing a 16-year-old founder's vision as a cornerstone of next-gen research tech.[1][2]
DELV has raised $36.0M in total across 2 funding rounds.
DELV's investors include 040 Capital, Alchemy Ventures, Archetype, Blockchain.com Ventures, Blockchange Ventures, Buckley Ventures, Dragonfly Capital Partners, Founders Fund, Galaxy Digital, General Catalyst, Greenfield One, Hack VC.
DELV has raised $36.0M across 2 funding rounds. Most recently, it raised $32.0M Series A in October 2021.